● Pharmacogenetics
-
ALDH Genetic Polymorphism
O lenei pusa o loʻo faʻaaogaina mo in vitro suʻesuʻega faʻapitoa o le ALDH2 gene G1510A polymorphism site i totonu ole DNA genomic toto tagata.
-
Tagata CYP2C9 ma VKORC1 Gene Polymorphism
O lenei pusa e faʻatatau i in vitro qualitative detection of polymorphism o CYP2C9 * 3 (rs1057910, 1075A> C) ma VKORC1 (rs9923231, -1639G> A) i le genomic DNA o faʻataʻitaʻiga toto atoa o tagata.
-
Tagata CYP2C19 Gene Polymorphism
O lenei pusa o loʻo faʻaaogaina mo in vitro qualitative suʻesuʻega o le polymorphism o CYP2C19 genes CYP2C19 * 2 (rs4244285, c.681G> A), CYP2C19 * 3 (rs4986893, c.636G> A), CYP2C12 * 147 (rs. genomic DNA ole toto atoa ole tagata.
-
Human Leukocyte Antigen B27 Nucleic Acid
O lenei pusa o loʻo faʻaaogaina mo le suʻesuʻeina lelei o le DNA i le leukocyte antigen subtypes HLA-B * 2702, HLA-B * 2704 ma HLA-B * 2705.
-
MTHFR Gene Polymorphic Nucleic Acid
O lenei pusa e faʻaaogaina e suʻe ai nofoaga e 2 suiga ole MTHFR gene. O lo'o fa'aogaina e le pusa le toto atoa o le tagata e fai ma fa'ata'ita'iga fa'ata'ita'iga e tu'uina atu ai se su'esu'ega fa'atatau o le tulaga o suiga. E mafai ona fesoasoani i foma'i e mamanuina fuafuaga mo togafitiga talafeagai mo uiga eseese o tagata ta'ito'atasi mai le tulaga mole, ina ia mautinoa le soifua maloloina o tagata mama'i i se tulaga sili.
